Alto Ingredients (ALTO) CCO receives 30,794-share stock award

Rhea-AI Filing Summary

Sneed James R reported acquisition or exercise transactions in this Form 4 filing.

Alto Ingredients, Inc. reported that Chief Commercial Officer James R. Sneed received a grant of 30,794 shares of Common Stock on March 17, 2026. The shares were awarded at no purchase price, increasing his directly held stake to 463,191 shares. This appears to be a routine equity compensation award rather than an open-market trade.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Sneed James R

Role Chief Commercial Officer

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	30,794	$0.00	--

Holdings After Transaction: Common Stock — 463,191 shares (Direct)

Footnotes (1)

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Sneed James R

(Last) (First) (Middle)

1300 SOUTH SECOND STREET

(Street)

PEKIN ILLINOIS 61554

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Alto Ingredients, Inc. [ ALTO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Commercial Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/17/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/17/2026		A		30,794	A	$0.00	463,191	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ James R. Sneed	03/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Alto Ingredients (ALTO) report for James R. Sneed?

Alto Ingredients reported that Chief Commercial Officer James R. Sneed received a grant of 30,794 shares of Common Stock. This was a share award, not an open-market purchase, and increased his directly held ownership to 463,191 shares after the transaction.

Was the Alto Ingredients (ALTO) Form 4 transaction a stock purchase or a grant?

The Form 4 transaction was a grant or award of shares, not a cash purchase. The filing classifies it under transaction code A, which indicates a grant, award, or other acquisition, with a reported price per share of zero dollars.

How many Alto Ingredients (ALTO) shares does James R. Sneed hold after this award?

After receiving the 30,794-share grant, James R. Sneed is reported to directly own 463,191 shares of Alto Ingredients Common Stock. This figure reflects his total direct holdings immediately following the reported equity award on March 17, 2026.

Does the Alto Ingredients (ALTO) Form 4 show any insider share sales?

The Form 4 does not report any insider share sales. It shows only one transaction, a grant of 30,794 shares classified as an acquisition (code A), with no corresponding sale or disposition transactions listed in the filing summary.

What role does James R. Sneed hold at Alto Ingredients (ALTO)?

James R. Sneed is identified as the Chief Commercial Officer of Alto Ingredients. The Form 4 indicates he is an officer of the company, and the reported transaction relates to a grant of Common Stock received in that capacity.

Is the Alto Ingredients (ALTO) insider transaction part of routine compensation?

The filing characterizes the event as a grant or award of shares, suggesting routine equity compensation. It uses transaction code A and a zero-dollar price per share, typical for stock awards given as part of an executive compensation package.